Thromboprophylaxis and treatment of thrombosis in pregnancy

Hematological Complications in Obstetrics, Pregnancy, and Gynecology

Volumn , Issue , 2006, Pages 200-221

  Heilmann, L ^a   Rath, W ^b   Bick, R L ^c  

^a Gesundheits und Pflegezentrum Russelsheim   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928420592     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511526978.007     Document Type: Chapter

References (84)

1. A Working Group on behalf of the Obstetric Medicine Group of Australasia: Anticoagulation in pregnancy and the puerperium. MJA, 175: 258, 2001.
2. ACOG Practice Bulletin: Thromboembolism in pregnancy. No 19, 2000.
3. Armour, R., Schwedler, M., Kerstein, M. D. Current assessment of thromboembolic disease and pregnancy. Am. Surgeon, 67: 641, 2001.
4. Backos, M., Chilcott, I., Rai, R. Pregnancy complications in women with recurrent miscarriage and antiphospholipid-antibodies treated with aspirin and heparin. Hum. Reprod., 12:61, 1997.
5. Bates, S. M., Ginsberg, J. S. How we manage venous thromboembolism during pregnancy. Blood, 100: 3470, 2002.
6. Bates, S.M., Ginsberg, J.S. Pregnancy and deep vein thrombosis. Seminars Vasc. Med., 1: 97, 2001.
7. Bergqvist D, Bergqvist A, Lindhagen A. Longterm outcome of patients with venous thromboembolism during pregnancy. In Greer, I. A., Turpie, A. G. C., Forbes, C. O., (eds.). Haemostasis and Thrombosis in Obstetrics and Gynecology. London; Chapman & Hall, 1992.
8. Bergqvist, D., Hedner, U. Pregnancy and venous thromboembolism. Acta Obstet. Gynecol. Scand., 62: 449, 1983.
9. Bockarewa, M. I., Bremme, K., Blombäck, M. Arg 506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br. J. Haematol., 92: 473, 1996.
10. Branch, D. W., Silver, R. M., Blackwell, J. L. Outcome of treated pregnancies in women with antiphosopholipid syndrome. An update of the Utah experience. Obstet. Gynecol., 4: 614, 1992.
11. Brenner, B., Blumenfeld, Z. Thrombophilia and fetal loss. Blood Rev., 11: 72, 1997.
12. Brenner, B., Kupferminc, M. J. Inherited thrombophilia and poor pregnancy outcome. Best Practice & Research Clinical Obstetrics & Gynaecology, 17: 427, 2003.
13. Brenner, B. Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - Yes. J. Thromb. Haemost., 1: 2070, 2003.
14. Brill-Edwards, P., Ginsberg, J. S., Gent, M., et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. NEJM, 343: 1439, 2000.
15. Carr, M. H., Towers, C. V., Eastenson, A. R., et al. Prolonged bedrest during pregnancy: Does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis? J. Maternal Fetal Med., 6: 264, 1997.
16. Chan, W. S., Ray, J. G., Murray, S., et al. Suspected pulmonary embolism in pregnancy. Arch. Intern. Med., 162: 1170, 2002.
17. Conard, J., Horellou, M. H., van Dreden, P. Pregnancy and congenital deficiency in antithrombin III or protein C. Thromb. Haemost., 58: 39, 1987.
18. Conard, J., Horellou, M. H., van Dreden, P. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S. Thromb. Haemost., 63: 319, 1990.
19. Crowther, M. A., Kelton, J. G. Congenital thrombophilic states associated with venous thrombosis: A qualitative overview and proposed classification system. Ann. Intern. Med., 138: 128, 2003.
20. Dahlback, B., Carlsson, M., Svensson, P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. PNAS, 90: 1004, 1993.
21. De Stefano, V., Leone, G., Mastrangelo, S., et al. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S. Thromb. Haemost., 71: 799, 1994.
22. De Stefano, V., Mastrangelo, S., Paciaroni, K. Thrombotic risk during pregnancy and puerperium in women with APC resistance-effective subcutaneous heparin prophylaxis in a pregnant patient. Thromb. Haemost., 74: 793, 1995.
23. De Stefano, V., Rossi, E., Paciaroni, K., et al. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica, 87: 1095, 2002.
24. De Swiet, M. Maternal mortality: Confidential enquiries into maternal deaths in the United Kingdom. Am. J. Obstet. Gynecol., 182: 760, 2000.
25. Dilley, A., Austin, H., El-Jamil, M., et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am. J. Obstet.Gynecol., 183: 1271, 2000.
26. Dizon-Townson, D. S., Nelson, L. M., Jang, H., et al. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am. J. Obstet. Gynecol., 176: 883, 1997.
27. Eldor, A. Thrombophilia, thrombosis and pregnancy. Thromb. Haemost., 86: 104, 2001.
28. Ensom, M. H. H., Stephenson, M. D. Low-molecular-weight heparins in pregnancy. Pharmacotherapy, 19: 1013, 1999.
29. Fausett, M. B., Vogtlander, M., Lee, R. M., et al. Heparin-induced thrombocytopenia is rare in pregnancy. Am. J. Obstet. Gynecol., 185: 148, 2001.
30. Friederich, P. W., Samson, B. J., Simioni, P. Frequency of pregnancy related thromboembolism in anticoagulant factor deficient women: Implications for prophylaxis. Ann. Intern. Med., 125: 955, 1996.
31. Gates, S. Thromboembolic disease in pregnancy. Curr. Opin. Obstet. Gynecol., 12: 117, 2000.
32. Gerhardt, A., Scharf, R. E., Beckmann, M. W., et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. NEJM, 342: 374, 2000.
33. Gerhardt, A., Scharf, R. E., Zotz, R. B. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb. Haemost., 90: 77, 2003.
34. Gherman, R. B., Goodwin, T. M., Leung, B., et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet. Gynecol., 94: 730, 1999.
35. Ginsberg, J. S., Bates, S. M. Management of venous thromboembolism during pregnancy. J. Thromb. Haemost., 1: 1435, 2003.
36. Ginsberg, J. S., Greer, I. A., Hirsh, J. Use of antithrombotic agents during pregnancy. Chest, 119: 122, 2001.
37. Ginsberg, J. S. Thromboembolism and pregnancy. Thromb. Haemost., 82: 620, 1999.
38. Girling, J., deSwiet, M. Inherited thrombophilia and pregnancy. Curr. Opin. Obstet. Gynecol., 10: 135, 1998.
39. Grandone, E., Margaglione, M., Colaizzo, D., et al. Genetic susceptibility to pregnancy- related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210 A, and methylenetetrahydrofolate reductase C677T mutations. Am. J. Obstet. Gynecol., 179: 1324, 1998.
40. Granger, K. A., Farquharson, R. G. Obstetric outcome in antiphospholipid syndrome. Lupus, 6: 509, 1997.
41. Greer, I. A. Epidemiology, risk factors and prophylaxis of venous thromboembolism in obstetrics and gynecology. Baillieres Clin. Obstet. Gynecol., 11: 403, 1997.
42. Greer, I. A. The special case of venous thromboembolism in pregnancy. Haemostasis, 28 (Suppl. 3): 22, 1998.
43. Greer, I.A., de Swiet, M. Thrombosis prophylaxis in obstetrics and gynecology. BJOG, 100: 37, 1993.
44. Hallak, M., Senderowicz, J., Cassel, A. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am. J. Obstet.Gynecol., 176: 889, 1997.
45. Heilmann, L., Rath, W., v. Tempelhoff, G. F., et al. The use of low molecular weight heparin (LMWH) in pregnancy. Geburtsh Frauenheilk, 61: 355, 2001.
46. Heilmann, L., Rath, W. Thrombophilia in Pregnancy. Bremen, London, New York; Unimed, 2002.
47. Hirsch, D. R., Mikkola, K. M., Marks, P. W. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use. Prevalence of factor V Leiden. Am. Heart J., 131: 1145, 1996.
48. Katano, K., Aoki, K., Sasa, H. Beta-2-glycoprotein-1-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum. Reprod., 11: 509, 1996.
49. Khare, M., Nelson-Piercy, C. Acquired thrombophilias and pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology, 17: 491, 2003.
50. Kovacevich, G. J., Gaich, S. A., Lavin, J. P., et al. The prevalence of thromboembolic events among women with extended bed rest prescribed as part of the treatment for premature labor or preterm premature rupture of membranes. Am. J. Obstet. Gynecol., 182: 1089, 2000.
51. Krnic-Barrie, S., O’Connor, C. R., Looney, S. W. A retrospective review of 61 patients with antiphospholipid syndrome. Arch. Intern. Med., 157: 2101, 1997.
52. Kupferminc, M. J., Eldor, A., Steinman, N. Increased frequency of genetic thrombophilia in women with complications of pregnancy. NEJM, 340: 9, 1999.
53. Kyrle, P. A., Minar, E., Hirschl, M., et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. NEJM, 343: 457, 2000.
54. Lepercq, J., Conard, J., Burel-Derlon, A., et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG, 108: 1134, 2001.
55. Lima, F., Khamashta, M. A., Buchanan, N. M. M. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin. Exp. Rheumatol., 14: 131, 1996.
56. Lindhagen, A., Bergqvist, A., Bergqvist, D. Late venous function in the leg after deep venous thrombosis occurring in relation to pregnancy. BJOG, 93: 348, 1986.
57. Lindqvist, P., Dahlback, B., Marsal, K. Thrombotic risk during pregnancy: A population study. Obstet. Gynecol., 94: 595, 1999.
58. Lindqvist, P. Risk estimation and prediction of preeclampsia, IUGR, and thrombosis in pregnancy (thesis). Malmӧ, Sweden, 1999.
59. Macklon, N. S., Greer, I. A. Venous thromboembolic disease in obstetrics and gynaecology. The Scottish experience. Scott. Med. J., 41: 83, 1996.
60. McColl, M.D., Ellison, J., Reid, F., et al. Prothrombin 202210 G–A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. BJOG, 107: 565, 2000.
61. McColl, M. D., Ramsay, J., Tait, R. Risk factors for pregnancy associated venous thromboembolism. Thromb. Haemost., 78: 1183, 1997.
62. McColl, M. D., Walker, I., Greer, I. A. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. BJOG, 106: 756, 1999.
63. Meroni, P.L., Moia, M., Derksen, R.H.W. M., et al. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis. Lupus, 12: 504, 2003.
64. Murphy, R. P., Donoghue, C., Nallen, R. J., et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylene-tetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler. Thromb. Vasc. Biol., 20: 266, 2000.
65. Nelson-Piercy, C. Prevention of thromboembolism in pregnancy. Scand. J. Rheumatol., 27 (Suppl. 107): 92, 1998.
66. Nguyen, A. Prothrombin G20210 A polymorphism and thrombophilia. Mayo Clin. Proc., 75: 595, 2000.
67. Pabinger, I., Grafenhofer, A., Kyrle, P.A., et al. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood, 100: 1060, 2002.
68. Pabinger, I., Schneider, B., For the Gesellschaft für Thrombose- und Hӓmostaseforschung (GTH) Study Group on Natural Inhibitor: Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. Arterioscler. Thromb. Vasc. Biol., 16: 742, 1996.
69. Rai, R. S., Clifford, K., Cohen, H., et al. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum. Reprod., 10: 3301, 1995.
70. Rand, H. J., Wu, X. X., Guller, S. Reduction of annexin V (placental anti-coagulant protein I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am. J. Obstet. Gynecol., 171: 1566, 1994.
71. Raschke, R., Hirsh, J., Guidry, J. R. Suboptimal monitoring and dosing of unfractionated heparin in comparative studies with low molecular heparin. Ann. Intern. Med., 138: 720, 2003.
72. Rath, W., Heilmann, L. Haemostatic Disorders in Obstetrics and Gynecology. New York, NY; Thieme Stuttgart, 1999.
73. Ray, J. G., Chan, W. S. Deep vein thrombosis during pregnancy and the puerperium: A metaanalysis of the period of risk and the leg of presentation. Obstet. Gynecol. Surv., 54: 265, 1999.
74. Rosendaal, F. R. Risk factors for venous thrombotic disease. Thromb. Haemost., 82: 610, 1999.
75. Rutherford, S.W., Montero, M., McSchee, W. Thromboembolic disease associated with pregnancy: An 11 year review. Am. J. Obstet. Gynecol., 164: 286, 1991.
76. Sanson, B. J., Lensing, A. W. A., Prin, M. H. Safety of low molecular weight heparin in pregnancy: A systematic review. Thromb. Haemost., 81: 668, 1999.
77. Silver, R. M., Draper, M. J., Scott, J. R. Clinical consequences of antiphospholipid antibodies: An historic cohort study. Obstet. Gynecol., 83: 372, 1994.
78. Simpson, E. L., Lawrenson, R. A., Nightingale, A. L., et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG, 108: 56, 2001.
79. Toglia, M. R., Weg, J. D. Venous thromboembolism during pregnancy. NEJM, 335: 108, 1996.
80. Tormene, D., Simioni, P., Prandoni, P., et al. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women. Haematologica, 86: 1305, 2001.
81. Van Walraven, C., Mamdani, M., Cohn, A., et al. Risk of subsequent thomboembolism for patients with pre-eclampsia. BMJ, 326: 791, 2003.
82. Vincente, V., Rodriguez, C., Soto, I. Risk of thrombosis during pregnancy and postpartum in hereditary thrombophilia. Am. J. Haematol., 46: 151, 1994.
83. Wilson, W. A., Gharavi, A. E., Koike, T., et al. International consensus statement on preliminary classification criteria for definite anti-phospholipid syndrome. Arthritis & Rheumatism, 42: 1309, 1999.
84. Zotz, R. B., Gerhardt, A., Scharf, R. E. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy. Seminars in Thromb. and Haemost., 29: 143, 2003.